These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8484355)

  • 1. Cocaine in the hair of mother-infant pairs: quantitative analysis and correlations with urine measures and self-report.
    Marques PR; Tippetts AS; Branch DG
    Am J Drug Alcohol Abuse; 1993; 19(2):159-75. PubMed ID: 8484355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of gestational cocaine exposure: sensitivity of infants' hair, meconium, and urine.
    Callahan CM; Grant TM; Phipps P; Clark G; Novack AH; Streissguth AP; Raisys VA
    J Pediatr; 1992 May; 120(5):763-8. PubMed ID: 1578314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Head growth in cocaine-exposed infants: relationship to neonate hair level.
    Sallee FR; Katikaneni LP; McArthur PD; Ibrahim HM; Nesbitt L; Sethuraman G
    J Dev Behav Pediatr; 1995 Apr; 16(2):77-81. PubMed ID: 7790518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cocaine detection in maternal and neonatal hair: implications to fetal toxicology.
    Garcia-Bournissen F; Rokach B; Karaskov T; Koren G
    Ther Drug Monit; 2007 Feb; 29(1):71-6. PubMed ID: 17304153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Value of toxicological research in newborn infants of addicted mothers by the study of several samples (urine, meconium, hair)].
    Sampériz S; Millet V; Arditti J; Lacroze V; Masset D; Bourdon H; Jouglard J; Unal D
    Arch Pediatr; 1996 May; 3(5):440-4. PubMed ID: 8763713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of gestational cocaine exposure by hair analysis.
    Graham K; Koren G; Klein J; Schneiderman J; Greenwald M
    JAMA; 1989 Dec; 262(23):3328-30. PubMed ID: 2585678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neonatal hair analysis for benzoylecgonine: a sensitive and semiquantitative biological marker for chronic gestational cocaine exposure.
    Katikaneni L; Salle FR; Hulsey TC
    Biol Neonate; 2002 Jan; 81(1):29-37. PubMed ID: 11803174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of cocaine usage in pregnant women by a urinary EMIT drug screen and GC-MS analyses.
    DiGregorio GJ; Ferko AP; Barbieri EJ; Ruch EK; Chawla H; Keohane D; Rosenstock R; Aldano A
    J Anal Toxicol; 1994 Sep; 18(5):247-50. PubMed ID: 7990440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transplacental pharmacokinetics of cocaine and benzoylecgonine in plasma and hair of rhesus monkeys.
    Bailey B; Morris P; McMartin KI; Klein J; Duhart HM; Gillam MP; Binienda Z; Slikker W; Paule MG; Koren G
    Reprod Toxicol; 1998; 12(5):517-23. PubMed ID: 9763243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concordance of three measures of cocaine use in an arrestee population: hair, urine, and self-report.
    Mieczkowski T; Barzelay D; Gropper B; Wish E
    J Psychoactive Drugs; 1991; 23(3):241-9. PubMed ID: 1774609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prenatal cocaine exposures and dose-related cocaine effects on infant tone and behavior.
    Chiriboga CA; Kuhn L; Wasserman GA
    Neurotoxicol Teratol; 2007; 29(3):323-30. PubMed ID: 17234383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cocaine exposure during pregnancy: improving assessment with radioimmunoassay of maternal hair.
    Grant T; Brown Z; Callahan C; Barr H; Streissguth AP
    Obstet Gynecol; 1994 Apr; 83(4):524-31. PubMed ID: 8134061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meconium analysis for improved identification of infants exposed to cocaine in utero.
    Ryan RM; Wagner CL; Schultz JM; Varley J; DiPreta J; Sherer DM; Phelps DL; Kwong T
    J Pediatr; 1994 Sep; 125(3):435-40. PubMed ID: 8071754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cocaine use during pregnancy: sensitive detection by hair assay.
    Kline J; Ng SK; Schittini M; Levin B; Susser M
    Am J Public Health; 1997 Mar; 87(3):352-8. PubMed ID: 9096533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methamphetamine detection in maternal and neonatal hair: implications for fetal safety.
    Garcia-Bournissen F; Rokach B; Karaskov T; Koren G
    Arch Dis Child Fetal Neonatal Ed; 2007 Sep; 92(5):F351-5. PubMed ID: 17077112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Biological Screening and Diagnostic Indicators to Detect In Utero Opiate and Cocaine Exposure Among Mother-Infant Dyads.
    Stabler M; Giacobbi P; Chertok I; Long L; Cottrell L; Yossuck P
    Ther Drug Monit; 2017 Dec; 39(6):640-647. PubMed ID: 28937537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indicators of cocaine exposure and preterm birth.
    Savitz DA; Henderson L; Dole N; Herring A; Wilkins DG; Rollins D; Thorp JM
    Obstet Gynecol; 2002 Mar; 99(3):458-65. PubMed ID: 11864674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cocaine metabolite (benzoylecgonine) in hair and urine of drug users.
    Martinez F; Poet TS; Pillai R; Erickson J; Estrada AL; Watson RR
    J Anal Toxicol; 1993; 17(3):138-42. PubMed ID: 8336486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical utilization of the neonatal hair test for cocaine: a four-year experience in Toronto.
    Ursitti F; Klein J; Koren G
    Biol Neonate; 1997; 72(6):345-51. PubMed ID: 9428994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological markers of intrauterine exposure to cocaine and cigarette smoking.
    Koren G; Klein J; Forman R; Graham K; Phan MK
    Dev Pharmacol Ther; 1992; 18(3-4):228-36. PubMed ID: 1306811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.